Ovarian Cancer Market Research Reports

Your Ovarian Cancer Market Guide with research reports, industry analysis, market forecasts, market share, size, etc.
RSS Sort By :
TITLE Price Buy Now More options

Global Markets Direct’s, ‘Metastatic Ovarian Cancer - Pipeline Review, H2 2015’, provides an overview of the Metastatic Ovarian Cancer’s therapeutic pipeline.This report provides comprehensive information on the...

$ 2000


GlobalData's Medical Devices sector report, "Ovarian Cancer Pipeline Review, 2015" provides an overview of Ovarian Cancer diagnostic tests currently in pipeline stage.The report provides comprehensive information on the pipeli...

$ 4000


This is a professional and in-depth study on the current state of the Ovarian Cancer Therapeutics industry.The report provides a ba...

$ 2800


Global Markets Direct's, ?Ovarian Cancer - Pipeline Review, H1 2015', provides an overview of the Ovarian Cancer's therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Ovari...

$ 2500


Global Markets Direct's, ?Epithelial Ovarian Cancer - Pipeline Review, H1 2015', provides an overview of the Epithelial Ovarian Cancer's therapeutic pipeline.This report provides comprehensive information on the therapeutic deve...

$ 2000


Metastatic Ovarian Cancer - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Metastatic Ovarian Cancer - Pipeline Review, H1 2015’, provides an overview of the Metastatic Ovarian Cancer’s therapeutic pipeline....

$ 2000


GBI Research, a leading business intelligence provider, has released its latest research report, ""Ovarian Cancer Therapeutics in Asia-Pacific Markets to 2020 Off-patent Chemo-regimens to Retain Dominance Despite New Launches""...

$ 4995


Global Markets Direct's, ?Ovarian Cancer Pipeline Review, H2 2014', provides an overview of the Ovarian Cancer's therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Ovarian Canc...

$ 2500


Global Markets Direct's, ?Metastatic Ovarian Cancer Pipeline Review, H2 2014', provides an overview of the Metastatic Ovarian Cancer's therapeutic pipeline.This report provides comprehensive information on the therapeutic develo...

$ 2000


Global Markets Direct's, ?Epithelial Ovarian Cancer Pipeline Review, H2 2014', provides an overview of the Epithelial Ovarian Cancer's therapeutic pipeline.This report provides comprehensive information on the therapeutic develo...

$ 2000


Ovarian cancer is a condition where a malignancy forms in the ovarian tissue and is caused by uncontrollable cell growth. It is one of the major gynaecological cancers worldwide and a leading cause of death. Ovarian cancer is difficult to diagnose...

$ 2000


GBI Research, has released the pharma report -""Ovarian Cancer Therapeutics in Major Developed Markets to 2020 Late-Stage Pipeline Focuses on Improved Progression Free-Surival and Targeted Therapies"". The current Ovarian cance...

$ 4995


Global Markets Direct's, ?Ovarian Cancer Pipeline Review, H1 2014', provides an overview of the Ovarian Cancer's therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Ovarian Canc...

$ 2500


Global Markets Direct's, ?Metastatic Ovarian Cancer - Pipeline Review, H1 2014', provides an overview of the Metastatic Ovarian Cancer's therapeutic pipeline.This report provides comprehensive information on the therapeutic deve...

$ 2000


GlobalData's clinical trial report, "Metastatic Ovarian Cancer Global Clinical Trials Review, H1, 2014" provides data on the Metastatic Ovarian Cancer clinical trial scenario. This report provides elemental information and data relat...

$ 2500


Epithelial Ovarian Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Epithelial Ovarian Cancer - Pipeline Review, H1 2014’, provides an overview of the Epithelial Ovarian Cancer’s therapeutic pipeline....

$ 2000


Ovarian Cancer Global Clinical Trials Review, H2, 2013 Summary GlobalData''s clinical trial report, “Ovarian Cancer Global Clinical Trials Review, H2, 2013" provides data on the Ovarian Cancer clinical trial scenario. This re...

$ 2500


Ovarian Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, ''Ovarian Cancer - Pipeline Review, H2 2013'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the ...

$ 2500


Metastatic Ovarian Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, ''Metastatic Ovarian Cancer - Pipeline Review, H2 2013'', provides an overview of the indication’s therapeutic pipeline. This report provid...

$ 2000


Epithelial Ovarian Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, ''Epithelial Ovarian Cancer - Pipeline Review, H2 2013'', provides an overview of the indication’s therapeutic pipeline. This report provid...

$ 2000

Email Us
Need Help?
Name
Email
Phone
Country
Subject
Comments

Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441
Subscription Option

Use our subscription option and keep yourself updated about the latest industry analysis reports. We have research reports for over 5000 micro markets; you can access and utilize them at economical budgets.

More about our Subscription option
Report Alerts

Get Email alerts about market research reports from industries and publishers of your interest: